⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 30, 2018Journal of Experimental & Clinical Cancer ResearchOpen Access

ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression

View Full Paper

Ask AI

Bookmark

Share

Abstract

Our findings indicate that ATF3 functions as a tumor suppressor in HCC through targeting and regulating CYR61.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2018) studied this question.

synapsesocial.com/papers/69d8f994d2f7327e70ae4b32 https://doi.org/10.1186/s13046-018-0919-8

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung CancerOriginal Research · 2001 · 132 citations
2Damage-induced neuronal endopeptidase (DINE) enhances axonal regeneration potential of retinal ganglion cells after optic nerve injuryOriginal Research · 2017 · 44 citations
3ATF3 Regulates the Stability of p53: A Link to CancerOriginal Research · 2006 · 80 citations
4Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cellsOriginal Research · 2014 · 66 citations
5Fas-Mediated Apoptosis Is Regulated by the Extracellular Matrix Protein CCN1 (CYR61) In Vitro and In VivoIn Vitro Study · 2009 · 70 citations